Litcius/Paper detail

Zanidatamab: First Approval

Susan J. Keam

2025Drugs9 citationsDOI

Topics & Concepts

MedicineDrug approvalHuman Epidermal Growth Factor Receptor 2OncologyAntibodyInternal medicineCancerPharmacologyCancer researchDrugImmunologyBreast cancerCholangiocarcinoma and Gallbladder Cancer StudiesColorectal Cancer Treatments and StudiesCancer Genomics and Diagnostics
Zanidatamab: First Approval | Litcius